Received Oct 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AH7z3 | IM / LA |
booster vaccination administered to patient at 9 years of age; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AH7z3, expiry date 30-SEP-2026) for prophylaxis. On 06-OCT-2025, the patient received Menveo (intramuscular, left arm). On 06-OCT-2025, an unknown time after receiving Menveo, the patient experienced inappropriate age at vaccine administration (Verbatim: booster vaccination administered to patient at 9 years of age). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK receipt date:10-OCT-2025 The reporter stated that, the booster vaccination administered to patient at 9 years of age. No further information was provided. The reporter did not consent to follow up.